...price hike in the last two years could fit Bruins' description. Chenodiol chenodeoxycholic acid from Leadiant Biosciences S.p.A....
...estimated total cost of €11.1 million ($12.2 million) for 2019, or €163,000 ($178,949) per patient. Leadiant...
...production is limited to small batches and is used by patients affiliated with the pharmacy. Leadiant’s...

...treat relapsed or refractory mycosis fungoides or Sézary syndrome, types of cutaneous T cell lymphoma Leadiant Biosciences S.p.A....

...a Priority Review voucher to Leadiant Biosciences Inc. The voucher was issued after FDA approved Leadiant's...
...to treat pediatric and adult patients with adenosine deaminase severe combined immunodeficiency (see "FDA Approves Leadiant...
...of Leadiant Biosciences S.p.A. (Rome, Italy). Leadiant Biosciences S.p.A., Rome, Italy Product: Revcovi elapegademase-lvlr (EZN-2279) Business: Endocrine/Metabolic Chris Lieu Revcovi, elapegademase (EZN-2279) Leadiant Biosciences S.p.A. Metabolic...

...lymphocyte counts and led to metabolite detoxification in 10 patients with ADA-SCID undergoing treatment with Leadiant's...
...receiving Revcovi. Leadiant expects to deliver an interim report to FDA in 2021. Minarich said Leadiant...
...subsidiary of Leadiant Biosciences S.p.A. (Rome, Italy). Leadiant Biosciences S.p.A., Rome, Italy Product: Revcovi elapegademase-lvlr (EZN-2279) Business: Endocrine/Metabolic Mary Romeo Elapegademase (EZN-2279) Leadiant Biosciences S.p.A. Adenosine...

...lymphocyte counts and led to metabolite detoxification in 10 patients with ADA-SCID undergoing treatment with Leadiant's...
...receiving Revcovi. Leadiant expects to deliver an interim report to FDA in 2021. Minarich said Leadiant...
...the U.S. subsidiary of Leadiant Biosciences S.p.A. (Rome, Italy). Mary Romeo Adagen (Brand), adenosine deaminase (Generic), PEG-adenosine deaminase (Informal) Elapegademase (EZN-2279) Leadiant Biosciences S.p.A....

...liver metastases. Next steps could include testing other primary bile acids in liver tumor models. Leadiant Biosciences S.p.A....

...THR-149, a KLKB1 inhibitor of undisclosed type, in preclinical testing for macular edema. Shire plc, Leadiant Biosciences S.p.A....

...NASDAQ:JAZZ), Mallinckrodt plc (NYSE:MNK), Orexigen Therapeutics Inc. (NASDAQ:OREX) and The Medicines Co. (NASDAQ:MDCO). The seventh, Leadiant...
...BioCentury Extra, Feb. 18) . Becky Simon AMAG Pharmaceuticals Inc. BioMarin Pharmaceutical Inc. Esperion Therapeutics Inc. Horizon Pharma plc Jazz Pharmaceuticals plc Leadiant Biosciences S.p.A. Mallinckrodt...